isoproterenol and 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole

isoproterenol has been researched along with 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Förstermann, U; Gath, I; Nawrath, H; Wegener, JW1
Kohr, MJ; Traynham, CJ; Wang, H; Ziolo, MT1

Other Studies

2 other study(ies) available for isoproterenol and 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole

ArticleYear
Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat.
    British journal of pharmacology, 1997, Volume: 122, Issue:7

    Topics: Adrenergic beta-Agonists; Animals; Calcium; Cyclic AMP; Cyclic GMP; Enzyme Activation; Female; Guanylate Cyclase; Indazoles; Isoproterenol; Male; Muscle, Smooth, Vascular; Myocardial Contraction; Myocardium; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Vasoconstriction

1997
Phosphodiesterase 5 restricts NOS3/Soluble guanylate cyclase signaling to L-type Ca2+ current in cardiac myocytes.
    Journal of molecular and cellular cardiology, 2009, Volume: 47, Issue:2

    Topics: Animals; Calcium Channels, L-Type; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 5; Enzyme Activation; Guanylate Cyclase; Indazoles; Ion Channel Gating; Isoproterenol; Mice; Models, Biological; Myocardial Contraction; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Phosphodiesterase 5 Inhibitors; Purinones; Receptors, Adrenergic, beta; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Soluble Guanylyl Cyclase

2009